Origins of the specificity of inhibitor P218 toward wild-type and mutant PfDHFR: a molecular dynamics analysis

References

• Adane, L., Bhagat, S., Arfeen, M., Bhatia, S., Sirawaraporn, R., Sirawaraporn, W., … Bharatam, P. V. (2014). Design and synthesis of guanylthiourea derivatives as potential inhibitors of Plasmodium falciparum dihydrofolate reductase enzyme. Bioorganic & Medicinal Chemistry Letters, 24, 613–617.
   PubMed Web of Science ®Google Scholar
• Adane, L., & Bharatam, P. V. (2009). 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme. Journal of Molecular Graphics and Modelling, 28, 357–367.10.1016/j.jmgm.2009.09.001
   PubMed Web of Science ®Google Scholar
• Adane, L., & Bharatam, P. V. (2010). Binding modes of 2, 4-diaminoquinazoline and 2, 4-diaminopteridine analogs to P. falciparum dihydrofolate reductase enzyme: Molecular docking studies. Indian Journal of Pharmaceutical Sciences, 72, 324–333.
   PubMed Web of Science ®Google Scholar
• Adane, L., & Bharatam, P. V. (2011). Computer-aided molecular design of 1H-imidazole-2, 4-diamine derivatives as potential inhibitors of Plasmodium falciparum DHFR enzyme. Journal of Molecular Modeling, 17, 657–667.10.1007/s00894-010-0756-y
   PubMed Web of Science ®Google Scholar
• Adane, L., Bharatam, P. V., & Sharma, V. (2010). A common feature-based 3D-pharmacophore model generation and virtual screening: Identification of potential Pf DHFR inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 25, 635–645.10.3109/14756360903393817
   PubMed Web of Science ®Google Scholar
• Adane, L., Patel, D., & Bharatam, P. V. (2010). Shape and chemical feature based 3D pharmacophore model generation and virtual screening: Identification of potential leads for P. falciparum DHFR enzyme inhibition. Chemical Biology & Drug Design, 75, 115–126.
   PubMed Web of Science ®Google Scholar
• Arfeen, M., Patel, D. S., Abbat, S., Taxak, N., & Bharatam, P. V. (2014). Importance of cytochromes in cyclization reactions: Quantum chemical study on a model reaction of proguanil to cycloguanil. Journal of Computational Chemistry, 35, 2047–2055.10.1002/jcc.v35.28
   PubMed Web of Science ®Google Scholar
• Basak, S. C., & Mills, D. (2010). Quantitative structure-activity relationships for cycloguanil analogs as PfDHFR inhibitors using mathematical molecular descriptors. SAR and QSAR in Environmental Research, 21, 215–229.10.1080/10629361003770951
   PubMed Web of Science ®Google Scholar
• Basak, S. C., Mills, D., & Hawkins, D. M. (2011). Characterization of dihydrofolate reductases from multiple strains of Plasmodium falciparum using mathematical descriptors of their inhibitors. Chemistry & Biodiversity, 8, 440–453.
   PubMed Web of Science ®Google Scholar
• Bhat, H. R., Ghosh, S. K., Prakash, A., Gogoi, K., & Singh, U. P. (2012). In vitro antimalarial activity and molecular docking analysis of 4-aminoquinoline-clubbed 1,3,5-triazine derivatives. Letters in Applied Microbiology, 54, 483–486.10.1111/lam.2012.54.issue-5
   PubMed Web of Science ®Google Scholar
• Bhat, H. R., Singh, U. P., Gahtori, P., Ghosh, S. K., Gogoi, K., Prakash, A., & Singh, R. K. (2013). Antimalarial activity and docking studies of novel bi-functional hybrids derived from 4-aminoquinoline and 1, 3, 5-triazine against wild and mutant malaria parasites as pf-DHFR inhibitor. RSC Advances, 3, 2942–2952.10.1039/c2ra21915h
   Web of Science ®Google Scholar
• Bras, J. L., & Durand, R. M. (2003). The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundamental & Clinical Pharmacology, 17, 147–153.
   PubMed Web of Science ®Google Scholar
• Carrington, H. C., Crowther, A. F., Davey, D. G., Levi, A. A., & Rose, F. L. (1951). A metabolite of ‘Paludrine’ with high antimalarial activity. Nature, 168, 1080.10.1038/1681080a0
   PubMed Web of Science ®Google Scholar
• Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., … Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26, 1668–1688.10.1002/(ISSN)1096-987X
   PubMed Web of Science ®Google Scholar
• Case, D. A., Darden, T. A., Cheatham Iii, T. E., Simmerling, C. L., Wang, J., Duke, R. E., … Roberts, B. P. (2010). AMBER 11. San Francisco: University of California , 142.
   Google Scholar
• Curd, F. H., Davey, D. G., & Rose, F. L. (1945). Studies on synthetic antimalarial drugs; some biguanide derivatives as new types of antimalarial substances with both therapeutic and causal prophylactic activity. Annals of Tropical Medicine and Parasitology, 39, 208–216.
   PubMed Web of Science ®Google Scholar
• Dasgupta, T., Chitnumsub, P., Kamchonwongpaisan, S., Maneeruttanarungroj, C., Nichols, S. E., Lyons, T. M., … Anderson, K. S. (2009). Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria. ACS Chemical Biology, 4, 29–40.10.1021/cb8002804
   PubMed Web of Science ®Google Scholar
• Dondorp, A. M., Nosten, F. O., Yi, P., Das, D., Phyo, A. P., Tarning, J., … Lee, S. J. (2009). Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine, 361, 455–467.10.1056/NEJMoa0808859
   PubMed Web of Science ®Google Scholar
• Falco, E. A., Goodwin, L. G., Hitchings, G. H., Rollo, I. M., & Russell, P. B. (1951). 2: 4 diaminopyrimidines – A new series of antimalarials. British Journal of Pharmacology and Chemotherapy, 6, 185–200.10.1111/(ISSN)1476-5381a
   PubMed Web of Science ®Google Scholar
• Fiser, A., & Šali, A. (2003). Modeller: Generation and refinement of homology-based protein structure models. Methods in Enzymology, 374, 461–491.10.1016/S0076-6879(03)74020-8
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., … Perry, J. K. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47, 1739–1749.10.1021/jm0306430
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., … Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49, 6177–6196.10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Gahtori, P., Ghosh, S. K., Parida, P., Prakash, A., Gogoi, K., Bhat, H. R., & Singh, U. P. (2012). Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1, 3, 5-triazine derivatives: A novel and potential antifolate lead for Pf-DHFR-TS inhibition. Experimental Parasitology, 130, 292–299.10.1016/j.exppara.2011.12.014
   PubMed Web of Science ®Google Scholar
• Glide. 2011. Version 5.7. New York, NY: Schrödinger, LLC.
   Google Scholar
• Gregson, A., & Plowe, C. V. (2005). Mechanisms of resistance of malaria parasites to antifolates. Pharmacological Reviews, 57, 117–145.10.1124/pr.57.1.4
   PubMed Web of Science ®Google Scholar
• Hecht, D., Cheung, M., & Fogel, G. B. (2008). QSAR using evolved neural networks for the inhibition of mutant PfDHFR by pyrimethamine derivatives. Biosystems, 92, 10–15.10.1016/j.biosystems.2007.10.005
   PubMed Web of Science ®Google Scholar
• Ivanetich, K. M., & Santi, D. V. (1990). Bifunctional thymidylate synthase-dihydrofolate reductase in protozoa. The FASEB Journal, 4, 1591–1597.
   PubMed Web of Science ®Google Scholar
• Jeanmougin, F., Thompson, J. D., Gouy, M., Higgins, D. G., & Gibson, T. J. (1998). Multiple sequence alignment with Clustal X. Trends in Biochemical Sciences, 23, 403–405.10.1016/S0968-0004(98)01285-7
   PubMed Web of Science ®Google Scholar
• Khuntawee, W., Rungrotmongkol, T., & Hannongbua, S. (2011). Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex. Journal of Chemical Information and Modeling, 52, 76–83.
   PubMed Web of Science ®Google Scholar
• Kumar, A., Srivastava, K., Raja Kumar, S., Siddiqi, M. I., Puri, S. K., Sexana, J. K., & Chauhan, P. (2011). 4-Anilinoquinoline triazines: A novel class of hybrid antimalarial agents. European Journal of Medicinal Chemistry, 46, 676–690.10.1016/j.ejmech.2010.12.003
   PubMed Web of Science ®Google Scholar
• LigPrep. 2011. Version 2.5. New York, NY: Schrödinger, LLC.
   Google Scholar
• Madapa, S., Tusi, Z., Sridhar, D., Kumar, A., Siddiqi, M. I., Srivastava, K., … Shiva Keshava, G. B. (2009). Search for new pharmacophores for antimalarial activity. Part I: Synthesis and antimalarial activity of new 2-methyl-6-ureido-4-quinolinamides. Bioorganic & Medicinal Chemistry, 17, 203–221.
   PubMed Web of Science ®Google Scholar
• Maestro. 2011. Version 9.2. New York, NY: Schrödinger, LLC.
   Google Scholar
• Maitarad, P., Kamchonwongpaisan, S., Vanichtanankul, J., Vilaivan, T., Yuthavong, Y., & Hannongbua, S. (2009). Interactions between cycloguanil derivatives and wild type and resistance-associated mutant Plasmodium falciparum dihydrofolate reductases. Journal of Computer-Aided Molecular Design, 23, 241–252.10.1007/s10822-008-9254-z
   PubMed Web of Science ®Google Scholar
• Maitarad, P., Saparpakorn, P., Hannongbua, S., Kamchonwongpaisan, S., Tarnchompoo, B., & Yuthavong, Y. (2009). Particular interaction between pyrimethamine derivatives and quadruple mutant type dihydrofolate reductase of Plasmodium falciparum: CoMFA and quantum chemical calculations studies. Journal of Enzyme Inhibition and Medicinal Chemistry, 24, 471–479.10.1080/14756360802201223
   PubMed Web of Science ®Google Scholar
• McKie, J. H., Douglas, K. T., Chan, C., Roser, S. A., Yates, R., Read, M., … Sirawaraporn, W. (1998). Rational drug design approach for overcoming drug resistance: Application to pyrimethamine resistance in malaria. Journal of Medicinal Chemistry, 41, 1367–1370.10.1021/jm970845u
   PubMed Web of Science ®Google Scholar
• Miller, B. R., McGee, T. D., Jr, Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8, 3314–3321.10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Mokmak, W., Chunsrivirot, S., Hannongbua, S., Yuthavong, Y., Tongsima, S., & Kamchonwongpaisan, S. (2014). Molecular dynamics of interactions between rigid and flexible antifolates and dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium falciparum. Chemical Biology & Drug Design, 84, 450–461.
   PubMed Web of Science ®Google Scholar
• Murray, C. J. L., Rosenfeld, L. C., Lim, S. S., Andrews, K. G., Foreman, K. J., Haring, D., … Lopez, A. D. (2012). Global malaria mortality between 1980 and 2010: A systematic analysis. The Lancet, 379, 413–431.10.1016/S0140-6736(12)60034-8
   PubMed Web of Science ®Google Scholar
• Nirmalan, N., Sims, P. F. G., & Hyde, J. E. (2004). Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors. Molecular and Biochemical Parasitology, 136, 63–70.10.1016/j.molbiopara.2004.02.013
   PubMed Web of Science ®Google Scholar
• Nzila, A. (2006). The past, present and future of antifolates in the treatment of Plasmodium falciparum infection. Journal of Antimicrobial Chemotherapy, 57, 1043–1054.10.1093/jac/dkl104
   PubMed Web of Science ®Google Scholar
• Ojha, P., & Roy, K. (2011). Exploring QSAR, pharmacophore mapping and docking studies and virtual library generation for cycloguanil derivatives as PfDHFR-TS inhibitors. Medicinal Chemistry, 7, 173–199.10.2174/157340611795564295
   PubMed Web of Science ®Google Scholar
• Peterson, D. S., Milhous, W. K., & Wellems, T. E. (1990). Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences, 87, 3018–3022.10.1073/pnas.87.8.3018
   PubMed Web of Science ®Google Scholar
• Peterson, D. S., Walliker, D., & Wellems, T. E. (1988). Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proceedings of the National Academy of Sciences, 85, 9114–9118.10.1073/pnas.85.23.9114
   PubMed Web of Science ®Google Scholar
• Powell, M. J. D. (1964). An efficient method for finding the minimum of a function of several variables without calculating derivatives. The Computer Journal, 7, 155–162.10.1093/comjnl/7.2.155
   Web of Science ®Google Scholar
• Rastelli, G., Sirawaraporn, W., Sompornpisut, P., Vilaivan, T., Kamchonwongpaisan, S., Quarrell, R., … Yuthavong, Y. (2000). Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: Structural basis of antifolate resistance. Bioorganic & Medicinal Chemistry, 8, 1117–1128.
   PubMed Web of Science ®Google Scholar
• Rieckmann, K. H., Yeo, A. E., & Edstein, M. D. (1996). Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 568–571.10.1016/S0035-9203(96)90326-0
   PubMed Web of Science ®Google Scholar
• Ryckaert, J.-P., Ciccotti, G., & Berendsen, H. J. (1977). Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics, 23, 327–341.10.1016/0021-9991(77)90098-5
   Web of Science ®Google Scholar
• Šali, A., & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology, 234, 779–815.10.1006/jmbi.1993.1626
   PubMed Web of Science ®Google Scholar
• Santos-Filho, O. A., & Hopfinger, A. J. (2001). A search for sources of drug resistance by the 4D-QSAR analysis of a set of antimalarial dihydrofolate reductase inhibitors. Journal of Computer-Aided Molecular Design, 15, 1–12.10.1023/A:1011152818340
   PubMed Web of Science ®Google Scholar
• Santos-Filho, O. A., Mishra, R. K., & Hopfinger, A. J. (2001). Free energy force field (FEFF) 3D-QSAR analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors. Journal of Computer-Aided Molecular Design, 15, 787–810.10.1023/A:1013199108020
   PubMed Web of Science ®Google Scholar
• Sardarian, A., Douglas, K. T., Read, M., Paul, F. G., Hyde, J. E., Chitnumsub, P., … Sirawaraporn, W. (2003). Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites. Organic & Biomolecular Chemistry, 1, 960–964.
   PubMed Web of Science ®Google Scholar
• Singh, K., Kaur, H., Chibale, K., Balzarini, J., Little, S., & Bharatam, P. V. (2012). 2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure–activity relationship and mode of action studies. European Journal of Medicinal Chemistry, 52, 82–97.10.1016/j.ejmech.2012.03.007
   PubMed Web of Science ®Google Scholar
• Singh, P., Singh, P., Kumar, M., Gut, J., Rosenthal, P. J., Kumar, K., … Bisetty, K. (2012). Synthesis, docking and in vitro antimalarial evaluation of bifunctional hybrids derived from β-lactams and 7-chloroquinoline using click chemistry. Bioorganic & Medicinal Chemistry Letters, 22, 57–61.
   PubMed Web of Science ®Google Scholar
• Sirichaiwat, C., Intaraudom, C., Kamchonwongpaisan, S., Vanichtanankul, J., Thebtaranonth, Y., & Yuthavong, Y. (2004). Target guided synthesis of 5-benzyl-2, 4-diamonopyrimidines: their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum. Journal of Medicinal Chemistry, 47, 345–354.10.1021/jm0303352
   PubMed Web of Science ®Google Scholar
• Sivaprakasam, P., Tosso, P. N., & Doerksen, R. J. (2009). Structure activity relationship and comparative docking studies for cycloguanil analogs as PfDHFR-TS inhibitors. Journal of Chemical Information and Modeling, 49, 1787–1796.10.1021/ci9000663
   PubMed Web of Science ®Google Scholar
• Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmougin, F., & Higgins, D. G. (1997). The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research, 25, 4876–4882.10.1093/nar/25.24.4876
   PubMed Web of Science ®Google Scholar
• Toyoda, T., Brobey, R. K. B., Sano, G.-I., Horii, T., Tomioka, N., & Itai, A. (1997). Lead discovery of inhibitors of the dihydrofolate reductase domain of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase. Biochemical and Biophysical Research Communications, 235, 515–519.10.1006/bbrc.1997.6814
   PubMed Web of Science ®Google Scholar
• Vanichtanankul, J., Taweechai, S., Uttamapinant, C., Chitnumsub, P., Vilaivan, T., Yuthavong, Y., & Kamchonwongpaisan, S. (2012). Combined spatial limitation around residues 16 and 108 of Plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil. Antimicrobial Agents and Chemotherapy, 56, 3928–3935.10.1128/AAC.00301-12
   PubMed Web of Science ®Google Scholar
• Verlet, L. (1967). Computer “experiments” on classical fluids. I. Thermodynamical properties of Lennard-Jones molecules. Physical Review, 159, 98–103.10.1103/PhysRev.159.98
   Web of Science ®Google Scholar
• Yuthavong, Y., Tarnchompoo, B., Vilaivan, T., Chitnumsub, P., Kamchonwongpaisan, S., Charman, S. A., … Bongard, E. (2012). Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target. Proceedings of the National Academy of Sciences, 109, 16823–16828.10.1073/pnas.1204556109
   PubMed Web of Science ®Google Scholar
• Yuvaniyama, J., Chitnumsub, P., Kamchonwongpaisan, S., Vanichtanankul, J., Sirawaraporn, W., Taylor, P., … Yuthavong, Y. (2003). Insights into antifolate resistance from malarial DHFR-TS structures. Nature Structural & Molecular Biology, 10, 357–365.
   Web of Science ®Google Scholar
• Zhang, K., & Rathod, P. K. (2002). Divergent regulation of dihydrofolate reductase between malaria parasite and human host. Science, 296, 545–547.10.1126/science.1068274
   PubMed Web of Science ®Google Scholar